Babraham, AZ and Pfizer in Open Innovation Alliance
BusinessWeekly reports that three Cambridge UK biomed technology powerhouses have reaffirmed their commitment to the open innovation agenda through a new initiative at the heart of the Cambridge cluster. The new collaboration aims to identify new therapeutic treatments, with the premise that early-stage collaboration maximizes success. Babraham Research
Comments Off on Babraham, AZ and Pfizer in Open Innovation Alliance • Read this story »